Screener
Intellia Therapeutics NTLA Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Intellia Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Intellia Therapeutics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-337952
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Marketable securities | 331,631 | 294,420 |
| Accounts receivable | 7,321 | 9,468 |
| Prepaid expenses and other current assets | 82,752 | 68,359 |
| Total current assets | 527,832 | 527,711 |
| Marketable securities - noncurrent | 190,595 | 155,250 |
| Property and equipment, net | 15,058 | 17,671 |
| Operating lease right-of-use assets | 85,954 | 105,955 |
| Investments and other assets | 37,725 | 35,540 |
Item 1. Financial Statements
FAQ
- What is Intellia Therapeutics's total current assets?
- Intellia Therapeutics (NTLA) reported total current assets of $527.83M in Q2 2026.
- How has Intellia Therapeutics's total current assets changed year-over-year?
- Intellia Therapeutics's total current assets increased by 6.4% year-over-year, from $495.95M to $527.83M.
- What is the long-term trend for Intellia Therapeutics's total current assets?
- Over 5 years (2020 to 2025), Intellia Therapeutics's total current assets has grown at a -3.1% compound annual growth rate (CAGR), from $616.52M to $527.71M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Intellia Therapeutics's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude